Chinese Medical Journal article review decodes GDF15 in prostate cancer metabolic character and therapies
Peer-Reviewed Publication
Updates every hour. Last Updated: 3-Apr-2026 07:15 ET (3-Apr-2026 11:15 GMT/UTC)
This review provides a comprehensive analysis of Growth Differentiation Factor 15 (GDF15) in prostate cancer (PCa), examining its complex influence on tumor metabolism, chemoresistance, and bone metastasis. GDF15 is identified as a critical driver of PCa progression and cancer cachexia, offering diagnostic potential as a biomarker, especially when combined with PSA. The review highlights promising ongoing clinical trials involving monoclonal antibodies (e.g., AV-380, NGM120, Visugromab) that target GDF15 signaling, marking it as a significant therapeutic opportunity for novel PCa therapie
A research team led by Dr. Dirk Henkensmeier at the Hydrogen and Fuel Cell Research Center of the Korea Institute of Science and Technology (KIST, President Sang-Rok Oh) has developed a novel membrane material for water electrolysis that operates stably and has significantly higher conductivity under low alkalinity conditions than existing systems. The newly developed membrane maintains high hydrogen production performance even in low-concentration alkaline environments, providing a technological foundation for low-alkalinity water electrolysis.
Researchers in China comprehensively identified 54 AhPR10 genes in cultivated peanut, phylogenetically classified into eight distinct subgroups with supported gene structure and motif conservation. Segmental duplication was identified as the primary driver for the expansion of the AhPR10 gene family, as revealed by chromosomal distribution and synteny analysis. The recombinant AhPR10-33 protein demonstrated significant antifungal activity by inhibiting Aspergillus flavus mycelial growth in vitro, highlighting its potential role in pathogen resistance.